267 related articles for article (PubMed ID: 18565575)
1. Neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole augment the effects of antidepressants acting via serotonergic system in the forced swimming test in rats.
Ulak G; Mutlu O; Akar FY; Komsuoğlu FI; Tanyeri P; Erden BF
Pharmacol Biochem Behav; 2008 Oct; 90(4):563-8. PubMed ID: 18565575
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide synthase inhibitors augment the effects of serotonin re-uptake inhibitors in the forced swimming test.
Harkin A; Connor TJ; Burns MP; Kelly JP
Eur Neuropsychopharmacol; 2004 Aug; 14(4):274-81. PubMed ID: 15163436
[TBL] [Abstract][Full Text] [Related]
3. The involvement of serotonergic system in the antidepressant effect of zinc in the forced swim test.
Szewczyk B; Poleszak E; Wlaź P; Wróbel A; Blicharska E; Cichy A; Dybała M; Siwek A; Pomierny-Chamioło L; Piotrowska A; Brański P; Pilc A; Nowak G
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):323-9. PubMed ID: 19150479
[TBL] [Abstract][Full Text] [Related]
4. The antidepressant-like action of metabotropic glutamate 7 receptor agonist N,N'-bis(diphenylmethyl)-1,2-ethanediamine (AMN082) is serotonin-dependent.
Pałucha-Poniewiera A; Brański P; Lenda T; Pilc A
J Pharmacol Exp Ther; 2010 Sep; 334(3):1066-74. PubMed ID: 20562216
[TBL] [Abstract][Full Text] [Related]
5. Clinical doses of citalopram or reboxetine differentially modulate passive and active behaviors of female Wistar rats with high or low immobility time in the forced swimming test.
Flores-Serrano AG; Vila-Luna ML; Álvarez-Cervera FJ; Heredia-López FJ; Góngora-Alfaro JL; Pineda JC
Pharmacol Biochem Behav; 2013 Sep; 110():89-97. PubMed ID: 23769836
[TBL] [Abstract][Full Text] [Related]
6. Effect of combined administration of 5-HT1A or 5-HT1B/1D receptor antagonists and antidepressants in the forced swimming test.
Tatarczyńska E; Kłodzińska A; Stachowicz K; Chojnacka-Wójcik E
Eur J Pharmacol; 2004 Mar; 487(1-3):133-42. PubMed ID: 15033385
[TBL] [Abstract][Full Text] [Related]
7. Antidepressant- and anxiolytic-like effects of selective neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole in mice.
Volke V; Wegener G; Bourin M; Vasar E
Behav Brain Res; 2003 Mar; 140(1-2):141-7. PubMed ID: 12644287
[TBL] [Abstract][Full Text] [Related]
8. Additive subthreshold dose effects of cannabinoid CB(1) receptor antagonist and selective serotonin reuptake inhibitor in antidepressant behavioral tests.
Takahashi E; Katayama M; Niimi K; Itakura C
Eur J Pharmacol; 2008 Jul; 589(1-3):149-56. PubMed ID: 18571641
[TBL] [Abstract][Full Text] [Related]
9. Nicotine, but not mecamylamine, enhances antidepressant-like effects of citalopram and reboxetine in the mouse forced swim and tail suspension tests.
Andreasen JT; Redrobe JP
Behav Brain Res; 2009 Jan; 197(1):150-6. PubMed ID: 18786574
[TBL] [Abstract][Full Text] [Related]
10. Behavioural effects of fluoxetine and tianeptine, two antidepressants with opposite action mechanisms, in rats.
Nowakowska E; Kus K; Chodera A; Rybakowski J
Arzneimittelforschung; 2000 Jan; 50(1):5-10. PubMed ID: 10683709
[TBL] [Abstract][Full Text] [Related]
11. Effects of reboxetine and citalopram pretreatment on changes in cocaine and amphetamine regulated transcript (CART) expression in rat brain induced by the forced swimming test.
Kang S; Kim HJ; Kim HJ; Shin SK; Choi SH; Lee MS; Shin KH
Eur J Pharmacol; 2010 Nov; 647(1-3):110-6. PubMed ID: 20826136
[TBL] [Abstract][Full Text] [Related]
12. Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment.
Cryan JF; Page ME; Lucki I
Psychopharmacology (Berl); 2005 Nov; 182(3):335-44. PubMed ID: 16001105
[TBL] [Abstract][Full Text] [Related]
13. Involvement of serotonin receptor subtypes in the antidepressant-like effect of TRIM in the rat forced swimming test.
Ulak G; Mutlu O; Tanyeri P; Komsuoglu FI; Akar FY; Erden BF
Pharmacol Biochem Behav; 2010 May; 95(3):308-14. PubMed ID: 20171242
[TBL] [Abstract][Full Text] [Related]
14. Hypobaric hypoxia exposure in rats differentially alters antidepressant efficacy of the selective serotonin reuptake inhibitors fluoxetine, paroxetine, escitalopram and sertraline.
Kanekar S; Sheth CS; Ombach HJ; Olson PR; Bogdanova OV; Petersen M; Renshaw CE; Sung YH; D'Anci KE; Renshaw PF
Pharmacol Biochem Behav; 2018 Jul; 170():25-35. PubMed ID: 29738811
[TBL] [Abstract][Full Text] [Related]
15. The effect of the NMDA receptor antagonist dizocilpine on behavioral manifestations of serotonin and adrenergic antidepressants in rats.
Pruus K; Rudissaar R; Allikmets L; Harro J
Methods Find Exp Clin Pharmacol; 2010 Mar; 32(2):123-8. PubMed ID: 20401349
[TBL] [Abstract][Full Text] [Related]
16. Increased sensitivity to antidepressants of D3 dopamine receptor-deficient mice in the forced swim test (FST).
Leggio GM; Micale V; Drago F
Eur Neuropsychopharmacol; 2008 Apr; 18(4):271-7. PubMed ID: 17804207
[TBL] [Abstract][Full Text] [Related]
17. Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents.
Brocco M; Dekeyne A; Veiga S; Girardon S; Millan MJ
Pharmacol Biochem Behav; 2002 Apr; 71(4):667-80. PubMed ID: 11888558
[TBL] [Abstract][Full Text] [Related]
18. Antidepressants differentially affect striatal amphetamine-stimulated dopamine and serotonin release in rats with high and low novelty-oriented behaviour.
O'Leary A; Kõiv K; Raudkivi K; Harro J
Pharmacol Res; 2016 Nov; 113(Pt B):739-746. PubMed ID: 26920253
[TBL] [Abstract][Full Text] [Related]
19. Idazoxan and 8-OH-DPAT modify the behavioral effects induced by either NA, or 5-HT, or dual NA/5-HT reuptake inhibition in the rat forced swimming test.
Rénéric JP; Bouvard M; Stinus L
Neuropsychopharmacology; 2001 Apr; 24(4):379-90. PubMed ID: 11182533
[TBL] [Abstract][Full Text] [Related]
20. Involvement of 5-HT(2C) receptors in the anti-immobility effects of antidepressants in the forced swimming test in mice.
Clenet F; De Vos A; Bourin M
Eur Neuropsychopharmacol; 2001 Apr; 11(2):145-52. PubMed ID: 11313160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
